Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors
US11613548B2 · kind B2 · utility
1Cited by
51References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2022 |
| Grant date | Mar 28, 2023 |
| Priority date | — |
| Expiry date | May 5, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are compounds of Formula (XVII) that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of Using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.